New observational study suggests use of combination vaccines may improve immunization coverage rates in infants

t vs. 43.5 percent; p<0.001); 3 doses of polio vaccine (71.9 percent vs. 49.6 percent; p<0.001); and 3 doses of hepatitis B vaccine (49.6 percent vs. 22.0 percent; p<0.001). In addition, higher coverage rates were also seen for the combination cohort compared to the component cohort for certain vaccines given in the second year of life: measles, mumps and rubella vaccine (MMR) (86.1 percent vs. 81.4 percent; p<0.001); varicella vaccine (86.1 percent vs. 81.4 percent; p<0.001); and Haemophilus influenzae type b (Hib) (71.7 percent vs. 55.9 percent; p<0.001). Coverage rates were also higher in the combination cohort compared to the component cohort for the 4:3:1:3:3:1 series combination (includes 4 doses of DTaP, 3 doses of polio, 1 dose of MMR, 3 doses of Hib, 3 doses of hepatitis B, and 1 dose of varicella vaccine (34.3 percent vs. 14.9 percent; p<0.001).

Results from this study suggest that incorporation of a combination vaccine into the routine immunization schedule for the first year of life may yield improved coverage rates, said Dr. Marshall. As suggested by improved coverage rates for the varicella and MMR vaccines, the effect might not be limited to the antigens contained in the combination vaccine. Overall, these results suggest that further research is warranted to determine the full impact of combination vaccines on the quality of immunization care.

Two additional observational studies of the Georgia Medicaid population, conducted by Dr. Marshall in collaboration with Applied Health Outcomes, were also presented at NIC today. The first assessed the impact of PEDIARIX on immunization timeliness in the same cohorts to determine if the infants studied received their vaccinations on time, based on the ACIP/AAFP/AAP recommended immunization schedule, or acceptably early as defined by Luman, et al in a previous study sponsored by the Centers for Disease Control and Prevention (CDC)*.

Results from the analysis showed that


Page: 1 2 3 4

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:

(Date:1/23/2020)... ... January 23, 2020 , ... GIOSTAR/HEAMGEN has developed ... cells. The red blood cells are made utilizing a bioreactor that permits ... therapy and replaces the need for a human blood donor. GIOSTAR/HEAMGEN ...
(Date:1/22/2020)... ... 2020 , ... Lifecycle Biotechnologies announces the new line of high purity powder chemicals ... on their process requirements and accurately weighed to 0.001 of a gram. The new line ... Sugars , Carbohydrates , Phosphates , Chelators ...
(Date:1/7/2020)... FORT WORTH, Texas (PRWEB) , ... January 07, ... ... of its 2020 prospectus. The Lifecycle prospectus features not just part numbers like ... business, it’s manufacturing facilities, the industries it supports, and that is all linked ...
Breaking Biology News(10 mins):
(Date:2/13/2020)... DUBLIN (PRWEB) , ... February 12, 2020 , ... ... affairs, and pharmacovigilance (PV) solutions and services, is adopting Veeva Vault Safety™ ... databases are a requirement for fast assessment of data, processing of safety information ...
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® , ... The National Organization for Rare Disorders (NORD), to raise awareness amongst the general public ... The Balancing Act’s “Behind The Mystery” rare disease series will be ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... ... of their RedySmart™ mass flow meters and controllers ideal for BioPharm ... an ideal upgrade to antiquated rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro ...
Breaking Biology Technology:
Cached News: